JAIME KEY: Open Payments
NPI 1285267559 · SPOKANE VALLEY, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,128 in 155 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $2,212 · 2025 $3,128
Food & beverage: $3,041Education: $87
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $490 |
| Corcept Therapeutics | 28 | $388 |
| ABBVIE INC. | 21 | $307 |
| Teva Pharmaceuticals USA, Inc. | 9 | $267 |
| AstraZeneca Pharmaceuticals LP | 11 | $231 |
| Xeris Pharmaceuticals, Inc. | 6 | $194 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $172 |
| Otsuka America Pharmaceutical, Inc. | 9 | $159 |
| Exact Sciences Corporation | 6 | $152 |
| Lundbeck LLC | 8 | $142 |
Products named: Korlym, REXULTI, Ozempic, Wegovy, RECORLEV, Kerendia, VRAYLAR, UBRELVY.
Industry payments across WA — which companies pay providers there.
